Becton Dickinson and Co vs SOLAI Limited — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while SOLAI Limited trades at $3.72 (market cap $16.69M). The key difference: Becton Dickinson and Co is far larger — about 2960.5× SOLAI Limited's market cap, and Becton Dickinson and Co pays a 2.32% dividend while SOLAI Limited pays none. Which is the better fit depends on your goals.
| BDX | SLAI | |
|---|---|---|
Market Cap | $49.41B | $16.69M |
Sector | Health | Technology |
52-Week High | $185.39 | $26.74 |
52-Week Low | $138.62 | $2.74 |
Enterprise Value | $65.51B | $16.33M |
Dividend Yield | 2.32% | — |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →